Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4315-4321

  Tam, Vincent H ^a   Schilling, Amy N ^a   Lewis, Russell E ^a   Melnick, David A ^b   Boucher, Adam N ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b ASTRAZENECA   (United Kingdom)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; MEROPENEM; TOBRAMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; THEORETICAL MODEL;

ALGORITHMS; COLONY COUNT, MICROBIAL; DATA INTERPRETATION, STATISTICAL; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; MICROBIAL SENSITIVITY TESTS; PILOT PROJECTS; PSEUDOMONAS AERUGINOSA; THIENAMYCINS; TOBRAMYCIN;

EID: 7244251629     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4315-4321.2004     Document Type: Article

References (20)

1. Bliss, C. I. 1939. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26:585-615.
2. Boucher, A. N., and V. H. Tam. Submitted for publication.
3. Cappelletty, D. M., and M. J. Rybak. 1996. Comparison of methodologies for synergism testing of drag combinations against resistant strains of Pseudomonas aemginosa. Antimicrob. Agents Chemother. 40:677-683.
4. Craig, W. A., and S. C. Ebert. 1990. Killing and regrowth of bacteria in vitro: a review. Scand. J. Infect. Dis. Suppl. 74:63-70.
5. D'Argenio, D. Z. 1981. Optimal sampling times for pharmacokinetic experiments. J. Pharmacokinet. Biopharm. 9:739-756.
6. Gold, H. S., and R. C. Moellering. 1996. Antimicrobial-drug resistance. N. Engl. J. Med. 335:1444-1453.
7. Greco, W. R., H. S. Park, and Y. M. Rustum. 1990. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D-arabinofuranosylcytosine. Cancer Res. 50:5318-5327.
8. Karakoc, B., and A. A. Gerceker. 2001. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 18:567-570.
9. Khinkis, L. A., L. Levasseur, H. Faessel, and W. R. Greco. 2003. Optimal design for estimating parameters of the 4-parameter Hill model. Nonlinearity Biol. Toxicol. Med. 1:363-377.
10. King, T. C., D. Schlessinger, and D. J. Krogstad. 1981. The assessment of antimicrobial combinations. Rev. Infect. Dis. 3:627-633.
11. Landman, D., J. M. Quale, D. Mayorga, A. Adedeji, K, Vangala, J. Ravishankar, C. Flores, and S. Brooks. 2002. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, N.Y.: the preantibiotic era has returned. Arch. Intern. Med. 162:1515-1520.
12. Lewis, R. E., D. J. Diekema, S. A. Messer, M. A. Pfaller, and M. E. Klepser. 2002. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J. Antimicrob. Chemother. 49:345-351.
13. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640.
14. Meletiadis, J., J. W. Mouton, J. F. Meis, and P. E. Verweij. 2003. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob. Agents Chemother. 47:106-117.
15. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
17. Perea, S., G. Gonzalez, A. W. Fothergill, W. R. Kirkpatrick, M. G. Rinaldi, and T. F. Patterson. 2002. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 46:3039-3041.
18. Rochon-Edouard, S., M. Pestel-Caron, J. F. Lemeland, and F. Caron. 2000. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 44:3055-3060.
19. Song, W., H. J. Woo, J. S. Kim, and K. M. Lee. 2003. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 21:8-12.
20. Te Dorsthorst, D. T., P. E. Verwejj, J. Meletiadis, M. Bergervoet, N. C. Punt, J. F. Meis, and J. W. Mouton. 2002. In vitro interaction of flucytosine combined with amphotencin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach. Antimicrob. Agents Chemother. 46:2982-2989.